Hereditary Hemorrhagic Telangiectasia (HHT)
Program Director: Mark Chesnutt, M.D.
Appointment Line: 503 494-7660
The OHSU Hereditary Hemorrhagic Telangiectasia Center of Excellence is a multidisciplinary center devoted to the evaluation and treatment of patients with Hereditary Hemorrhagic Telangiectasia (HHT). The OHSU HHT Center includes physicians who are among the most experienced in evaluating and treating patients with HHT and is one of a group of specialized centers that have been established with the support of the HHT Foundation, International. HHT patients in the Pacific Northwest and other regions of the Western United States can enjoy immediate access to a comprehensive HHT care center. The Center has special interest and expertise in the evaluation and management of pulmonary arteriovenous malformations (PAVMs).